Invesco’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.74M Sell
317,643
-16,657
-5% -$333K ﹤0.01% 2046
2025
Q4
$5.45M Buy
334,300
+58,537
+21% +$884K ﹤0.01% 2207
2025
Q3
$3.22M Buy
275,763
+74,024
+37% +$965K ﹤0.01% 2422
2025
Q2
$2.34M Buy
201,739
+10,407
+5% +$94.9K ﹤0.01% 2518
2025
Q1
$1.67M Buy
191,332
+73,265
+62% +$924K ﹤0.01% 2617
2024
Q4
$1.7M Buy
118,067
+21,134
+22% +$334K ﹤0.01% 2678
2024
Q3
$2.19M Sell
96,933
-3,485
-3% -$72K ﹤0.01% 2566
2024
Q2
$1.95M Buy
100,418
+16,607
+20% +$435K ﹤0.01% 2585
2024
Q1
$3.15M Sell
83,811
-2,251,127
-96% -$98.9M ﹤0.01% 2465
2023
Q4
$131M Buy
2,334,938
+108,472
+5% +$4.72M 0.03% 680
2023
Q3
$91.8M Buy
2,226,466
+354,680
+19% +$18.5M 0.02% 747
2023
Q2
$105M Buy
1,871,786
+204,123
+12% +$11M 0.03% 708
2023
Q1
$93M Buy
1,667,663
+1,590,355
+2,057% +$74.3M 0.03% 743
2022
Q4
$2.82M Sell
77,308
-53,570
-41% -$1.75M ﹤0.01% 2505
2022
Q3
$3.73M Buy
130,878
+2,482
+2% +$94.6K ﹤0.01% 2366
2022
Q2
$5.81M Sell
128,396
-5,695
-4% -$295K ﹤0.01% 2205
2022
Q1
$10.2M Sell
134,091
-47,119
-26% -$4.12M ﹤0.01% 1951
2021
Q4
$27M Sell
181,210
-370,446
-67% -$56.7M 0.01% 1366
2021
Q3
$80.3M Sell
551,656
-656,798
-54% -$113M 0.02% 879
2021
Q2
$237M Sell
1,208,454
-94,878
-7% -$17.2M 0.06% 443
2021
Q1
$236M Buy
1,303,332
+198,217
+18% +$34.2M 0.06% 399
2020
Q4
$156M Sell
1,105,115
-687,718
-38% -$99.8M 0.05% 537
2020
Q3
$224M Buy
1,792,833
+478,366
+36% +$50.2M 0.08% 318
2020
Q2
$117M Buy
1,314,467
+59,445
+5% +$4.63M 0.04% 533
2020
Q1
$78.2M Buy
1,255,022
+790,769
+170% +$61.7M 0.03% 600
2019
Q4
$35.4M Buy
464,253
+103,661
+29% +$6.23M 0.01% 1136
2019
Q3
$18.2M Buy
+360,592
New +$20M ﹤0.01% 1456

Other funds holding TXG